ChemoCentryx
CCXI
#3655
Rank
NZ$6.25 B
Marketcap
NZ$86.94
Share price
0.00%
Change (1 day)
27.22%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: NZ$6.25 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.25 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$958.07 B 15,222.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$251.87 B 3,928.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$647.33 B 10,252.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$331.52 B 5,201.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$45.47 B 627.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$500.20 B 7,899.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$202.62 B 3,140.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$198.55 B 3,075.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$67.92 B 986.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel